Lack of cross-reactivity between cefotaxime and imipenem.
Aouam
K
K
Ben Romdhane
F
F
Loussaief
C
C
Chakroun
M
M
Boughattas
N A
NA
Bouzouaia
N
N
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002439:Cefotaxime / Q000009:adverse effects* / Q000627:therapeutic use; D005076:Exanthema / Q000139:chemically induced*; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use*; D008297:Male; D013557:Switzerland
D000900:Anti-Bacterial Agents; D015378:Imipenem; D002439:Cefotaxime